Elanco Animal Health Inc. Overview

Elanco Animal Health Incorporated, a prominent player in the health care sector, specializes in the development, manufacturing, and marketing of products for companion and food animals. Based in Greenfield, United States, Elanco serves a global clientele through its online platform at www.elanco.com . The company is publicly traded on the New York Stock Exchange and made its initial public offering (IPO) on September 20, 2018.

Financial Snapshot

As of May 22, 2025, Elanco’s stock closed at $12.66. Over the past year, the stock has experienced significant fluctuations, reaching a 52-week high of $18.8 on June 11, 2024, and a 52-week low of $8.02 on April 16, 2025. The company’s market capitalization stands at approximately $6.29 billion USD. Despite these fluctuations, Elanco’s price-to-earnings ratio is currently 76.3511, indicating investor sentiment and market expectations.

Industry and Sector

Elanco operates within the health care sector, specifically in the pharmaceuticals industry. The company focuses on innovative solutions for animal health, addressing the needs of both companion and food animals. This specialization positions Elanco as a key player in the global animal health market.

Global Reach and Operations

With a strong presence in the United States and a global outreach through its website, Elanco Animal Health Inc. caters to a diverse range of clients worldwide. The company’s commitment to animal health is reflected in its extensive product portfolio and ongoing research and development efforts.

Conclusion

Elanco Animal Health Inc. continues to be a significant entity in the animal health sector, with a robust financial standing and a strategic focus on innovation and global service. As the company navigates market dynamics, its performance remains a point of interest for investors and stakeholders in the health care and pharmaceutical industries.